170 related articles for article (PubMed ID: 20402794)
1. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
[TBL] [Abstract][Full Text] [Related]
2. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
De Bernardis F; Lucciarini R; Boccanera M; Amantini C; Arancia S; Morrone S; Mosca M; Cassone A; Santoni G
Infect Immun; 2006 Jul; 74(7):4282-94. PubMed ID: 16790803
[TBL] [Abstract][Full Text] [Related]
4. Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis.
Piccinni MP; Vultaggio A; Scaletti C; Livi C; Gomez MJ; Giudizi MG; Biagiotti R; Cassone A; Romagnani S; Maggi E
J Infect Dis; 2002 Jul; 186(1):87-93. PubMed ID: 12089666
[TBL] [Abstract][Full Text] [Related]
5. Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.
Santoni G; Boccanera M; Adriani D; Lucciarini R; Amantini C; Morrone S; Cassone A; De Bernardis F
Infect Immun; 2002 Sep; 70(9):4791-7. PubMed ID: 12183521
[TBL] [Abstract][Full Text] [Related]
6. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.
De Bernardis F; Liu H; O'Mahony R; La Valle R; Bartollino S; Sandini S; Grant S; Brewis N; Tomlinson I; Basset RC; Holton J; Roitt IM; Cassone A
J Infect Dis; 2007 Jan; 195(1):149-57. PubMed ID: 17152019
[TBL] [Abstract][Full Text] [Related]
7. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.
de Bernardis F; Santoni G; Boccanera M; Spreghini E; Adriani D; Morelli L; Cassone A
Infect Immun; 2000 Jun; 68(6):3297-304. PubMed ID: 10816477
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
[TBL] [Abstract][Full Text] [Related]
9. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
10. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.
Pietrella D; Rachini A; Torosantucci A; Chiani P; Brown AJ; Bistoni F; Costantino P; Mosci P; d'Enfert C; Rappuoli R; Cassone A; Vecchiarelli A
Vaccine; 2010 Feb; 28(7):1717-25. PubMed ID: 20038431
[TBL] [Abstract][Full Text] [Related]
11. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis.
De Bernardis F; Boccanera M; Adriani D; Girolamo A; Cassone A
Infect Immun; 2002 May; 70(5):2725-9. PubMed ID: 11953420
[TBL] [Abstract][Full Text] [Related]
12. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
13. Human natural yeast killer toxin-like candidacidal antibodies.
Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
Chami F; Chami N; Bennis S; Trouillas J; Remmal A
J Antimicrob Chemother; 2004 Nov; 54(5):909-14. PubMed ID: 15456732
[TBL] [Abstract][Full Text] [Related]
15. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
[TBL] [Abstract][Full Text] [Related]
16. Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not.
Lee JY; Lee JH; Park JH; Kim SY; Choi JY; Lee SH; Kim YS; Kang SS; Jang EC; Han Y
Int Immunopharmacol; 2009 May; 9(5):632-8. PubMed ID: 19264152
[TBL] [Abstract][Full Text] [Related]
17. Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection.
Hamad M; Muta'eb E; Abu-Shaqra Q; Fraij A; Abu-Elteen K; Yasin SR
Mycoses; 2006 Mar; 49(2):104-8. PubMed ID: 16466442
[TBL] [Abstract][Full Text] [Related]
18. Mildly oxidized low-density lipoprotein inhibits the in vitro induction of the specific antibody response to Candida albicans.
Giordani L; Mattioli B; Quaranta MG; Giacomini E; Libri I; Varì R; Masella R; Viora M
Free Radic Biol Med; 2005 Oct; 39(7):960-9. PubMed ID: 16140215
[TBL] [Abstract][Full Text] [Related]
19. Active and passive immunization against oral Candida albicans infection in a murine model.
Farah CS; Ashman RB
Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
[TBL] [Abstract][Full Text] [Related]
20. A mannoprotein constituent of Candida albicans cooperates with antigen in the induction of a specific primary antibody response in cultures of human lymphocytes.
Luzzati AL; Giacomini E; Torosantucci A; Giordani L; Cassone A
J Biol Regul Homeost Agents; 1990; 4(4):142-9. PubMed ID: 2096599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
